OCUL Stock Analysis: Buy, Sell, or Hold?
OCUL - Ocular Therapeutix, Inc.
$8.33
-0.14 (-1.65%)
▼
5d:
+0.0%
30d:
-22.58%
90d:
-31.72%
HOLD
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 04, 2026
Smart Money Accumulation
OCUL is down 7.7% this week, but smart money is accumulating calls. Top strike: $10 2026-06-18 with 2,890 OI. Call ratio: 96% View Scanner →
Strength: 8.5/10
Get Alerted When OCUL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OCUL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: OCUL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: OCUL is currently trading at $8.33, which is considered slightly low relative to its 30-day fair value range of $8.02 to $10.00.
Technical Outlook: Technically, OCUL is in a strong uptrend. Immediate support is located at $7.38, while resistance sits at $8.75.
Market Sentiment: OCUL has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $26.00 (+212.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OCUL is in a strong uptrend. Immediate support is located at $7.38, while resistance sits at $8.75.
Market Sentiment: OCUL has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $26.00 (+212.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$8.02 -
$10.00
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding OCUL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 212.1% below Wall St target ($26.00)
Fair Price Analysis
30-Day Fair Range
$8.02 -
$10.00
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$7.38
Resistance Level
$8.75
Current Trend
Strong Uptrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.63
Wall Street Target
$26.00
(+212.1%)
Revenue Growth (YoY)
-22.4%
Share & Embed Analysis
Last updated: April 02, 2026 7:42 AM ET
Data refreshes hourly during market hours. Next update: 8:42 AM
Data refreshes hourly during market hours. Next update: 8:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OCUL showing a specific setup today?
Insider Activity (6 Months)
1
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Peter Kaiser
SELL
2810 shares
2026-02-23
Pravin Dugel
SELL
20056 shares
2026-02-23
Sanjay Nayak
SELL
1759 shares
2026-02-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$873 | 66 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 59 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 55 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 60 HOLD |
Advanced OCUL Option Strategies
Professional options setups generated by AI based on today's OCUL price and gamma walls.
